BioDuro-Sundia
↗Irvine, USA
BioDuro-Sundia is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) that provides fully integrated services from drug discovery to commercial manufacturing. Formed by the 2020 merger of BioDuro and Sundia MediTech, the company is one of the largest CRDMOs in the industry, offering a 'one-stop-shop' for biopharmaceutical partners.
The company specializes in small molecule and large molecule discovery, development, and scale-up, with unique technology platforms such as bioavailability enhancement (BRI) and solubility enhancement (Solu-Z). It is backed by Advent International and operates major R&D and manufacturing centers across the United States and China.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$500M-$1B
Founded:2005
Ownership:private
Status:operating
FUNDING
Stage:Pre-IPO
Total Raised:Not Disclosed
Investors:Advent International, Bridgewest Group
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, mAb, ADC, Peptide, Oligonucleotide
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Advent International
Subsidiaries:Sundia MediTech, Formex, Molecular Response
Key Partnerships:DigmBio (PARP1 inhibitor development), X-Chem (DEL services partnership), StoneWise (AI-driven drug discovery), Inna Pharma (CMC collaboration)
COMPETITION
Position:Leader
Competitors:WuXi AppTec, Pharmaron, Charles River Laboratories, Lonza, Catalent, Curia
LEADERSHIP
Key Executives:
Dr. Armin Spura - CEO
Yaohui Ji - Global President, CMC
Dr. Hong Wan - SVP, DMPK
Scientific Founders:Masood Tayebi
Board Members:David Preston (Chairman), Christopher Conway, Cathy Yen
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with BioDuro-Sundia. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.